Yuki Ikeda
Overview
Explore the profile of Yuki Ikeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yane K, Hanada K, Morita K, Yoshida K, Hirokawa S, Ikeda Y, et al.
Endoscopy
. 2025 Mar;
57(S 01):E226-E227.
PMID: 40074223
No abstract available.
2.
Maemura K, Ikeda Y, Iikura S, Takigami Y, Eda Y, Oki T, et al.
Heart Vessels
. 2025 Mar;
PMID: 40047891
Heart rate (HR) is a surrogate of systemic conditions, cardiac performances, and effect of chronotropic agents in patients with critical illness. The current study aimed to elucidate the association between...
3.
Ikeda Y, Yamashita N, Ito N, Minamikawa N, Okamura H, Yashiro T, et al.
Biosci Biotechnol Biochem
. 2024 Dec;
PMID: 39732622
Here, we examined the immunomodulating effects of Heyndrickxia coagulans SANK70258 (SANK70258). Mouse splenocytes treated with γ-ray-irradiated SANK70258 produced higher levels of IFN-γ than those with 7 types of lactic acid...
4.
Nishimoto S, Debarbat A, Ikeda Y, Arikawa E, Odagaki Y, Yano H, et al.
J Agric Food Chem
. 2024 Dec;
73(1):617-624.
PMID: 39714016
In mammals, intestinal α-glucosidase exists as a maltase-glucoamylase complex (MGAM) and a sucrase-isomaltase complex (SI). In this study, we transiently expressed human MGAM and SI in human embryonic kidney 293...
5.
Ikeda Y, Yuki R, Saito Y, Nakayama Y
FASEB J
. 2024 Dec;
38(24):e70261.
PMID: 39698932
SUMOylation, the modification of proteins with a small ubiquitin-like modifier (SUMO), is known to regulate various cellular events, including cell division. This process is dynamic, with its status depending on...
6.
Ikeda Y, Ishii S, Nakahara S, Iikura S, Fujita T, Iida Y, et al.
Eur Heart J Acute Cardiovasc Care
. 2024 Nov;
14(2):93-103.
PMID: 39560117
Aims: Complication management is crucial in patients receiving mechanical circulatory devices. However, there are limited data on the association between the risks of complications and device type in patients with...
7.
Kitasato L, Yamaoka-Tojo M, Iwaya T, Murayama Y, Ikeda Y, Hashikata T, et al.
J Vasc Res
. 2024 Nov;
62(1):22-36.
PMID: 39496251
Introduction: The vascular endothelial glycocalyx, crucial for blood vessel integrity and homeostasis, is vulnerable to oxidative stress, leading to endothelial dysfunction, which strongly correlates with cardiovascular disease (CVD). This study...
8.
Kuwahara Y, Tashiro H, Takeshita G, Egashira Y, Maruyama A, Ikeda Y, et al.
Respir Investig
. 2024 Oct;
62(6):1191-1194.
PMID: 39442268
A pleural effusion is a common pulmonary manifestation of systemic lupus erythematosus (SLE), and differential diagnosis is needed to perform targeted treatments. An SLE patient with refractory chylothorax is presented....
9.
Shimizu K, Tabata T, Iwakawa M, Ikeda Y, Ikeda T, Nonaka S, et al.
Intern Med
. 2024 Oct;
PMID: 39428536
Objective Angiotensin receptor-neprilysin inhibitors (ARNIs) have been widely used as a treatment for heart failure. However, they have only been approved for the treatment of hypertension in a limited number...
10.
Kanzaki S, Ogawa A, Ikeda Y, Iwakawa M, Nakagami T, Kido S, et al.
Int Heart J
. 2024 Sep;
65(5):866-872.
PMID: 39343591
Balance dysfunction in older patients compromises independence and increases the risk of falls and disability. Arterial stiffness, an important parameter of atherosclerosis, can affect peripheral organs, including the brain, causing...